Category: Acad, Gov/Utilities
GE Healthcare Receives FDA Approval of First-Ever Software to Help Automate Anesthesia Delivery and Reduce Greenhouse Gas Emissions During Surgery
CHICAGO – April 4, 2022 – GE Healthcare announced today the FDA pre-market approval (PMA) for its End-tidal (Et) Control software for general anesthesia delivery on its Aisys CS2Anesthesia Delivery System. GE Healthcare is the only manufacturer approved to offer general anesthesia delivery with end-tidal concentration control in the U.S. The company initially released the... Read more
Celebrating Female Scientists on International Women’s Day 2022
Female scientists are leading ground-breaking research across the world. We at ZEISS strive to #breakthebias by celebrating the fascinating female researchers we have been fortunate to meet in the last year. Learn more about our featured female microscopists who are contributing to advancements across many different fields of science: Dr Kelly Rogers, laboratory head &... Read more
FDA approves Roche’s Vabysmo, the first bispecific antibody for the eye, to treat two leading causes of vision loss
Vabysmo (faricimab-svoa) targets and inhibits two disease pathways that drive neovascular or “wet” age-related macular degeneration (nAMD) and diabetic macular edema (DME) Vabysmo is the only injectable eye medicine approved simultaneously in the US for nAMD and DME, with flexible dosing regimens based on patient need Basel, 31 January 2022 – Roche (SIX: RO, ROG; OTCQX:... Read more
Roche’s Evrysdi (risdiplam) granted FDA priority review for treatment of pre-symptomatic babies under 2 months of age with spinal muscular atrophy (SMA)
Interim data submitted to the FDA show majority of pre-symptomatic babies treated with Evrysdi for at least one year were able to sit, stand and walk within timeframes typical of healthy babies, as well as maintain swallowing Evrysdi is approved in 70 countries and submitted in a further 31 with more than 4,500 patients treated... Read more
Xylem and Isle Utilities Partner to Help Water Utilities Pilot and Scale Innovative Water Technology
New Funding Source for Trials of New Technologies That Reduce Carbon Emissions RYE BROOK, N.Y.–(BUSINESS WIRE)–Jan. 11, 2022– Global water technology leader, Xylem (NYSE:XYL), today announced it is sponsoring an innovative new funding mechanism for water utilities to deploy promising new technologies. The partnership with water consultancy Isle Utilities is a new approach to funding... Read more